Africa: Johnson & Johnson Announces Lead COVID-19 Vaccine Candidate, Commits to Supply 1 Billion Worldwide

[JNJ] Johnson & Johnson (NYSE: JNJ) (the Company) today announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the significant expansion of the existing partnership between the Janssen Pharmaceutical Companies of Johnson & Johnson and the Biomedical Advanced Research and Development Authority (BARDA); and the rapid scaling of the Company's manufacturing capacity with the goal of providing global supply of more than one billion doses oRead the Original Article

en_USEN